Tempus: Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a...

Paige: Oncoclínicas&Co Utilizes Paige’s AI-Assisted Diagnostic Applications to Enhance Diagnostic Capabilities and Further Support Patient Safety NEW YORK & SÃO PAULO--(BUSINESS WIRE)--Paige, a leader in...

Paige: Built on over 2.3 million whole-slide images and integrated with Microsoft’s Phi-3, PRISM2 sets a new benchmark in performance, interpretability, and large language model compatibility Paige, a leader in next-generation AI technology,...

Paige and Breast International Group (BIG): The global partnership will leverage Paige’s technology to reduce unnecessary treatment, support better patient stratification, and help standardize the measurement of residual cancer...

LINKÖPING, Sweden, April 8, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be...

Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI...